National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 Clinical Management

• Main Authors: E. Nicastri, N. Petrosillo, L. Lepore, A. Mondi, T. Ascoli Marchetti, D’Offizi G., F. Palmieri, L. Marchioni, S. Murachelli, G. Ippolito, A. Antinori, INMI COVID-19 Treatment Group (ICOTREG)
• Format: Article
• Language: English
• Published: MDPI AG 2020-03-01
• Series: Infectious Disease Reports
• Subjects: COVID-19; SARS-CoV-2; Treatment
• Online Access: https://www.pagepress.org/journals/index.php/idr/article/view/8543
• ISSN: 2036-7430; 2036-7449

On January 9 2020, the “World Health Organization” (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a diseases (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; these recomendations should be considered as expert opinions, which may be modified according to newly produced literature data.